ST. LOUIS - TelAve -- NOUS Imaging, a medical imaging software company, today announced that the FDA has cleared its 510(k) submission for FIRMM, Framewise Integrated Real-Time MRI Monitoring. FIRMM provides real-time monitoring and biofeedback that addresses the significant problem of patient motion during brain MRI. This is the Company's first FDA clearance and represents the initial piece of a larger software platform designed to deliver next-generation imaging enhancements for MRI.

FIRMM is a software accessory to an MRI scanner used to calculate and display patient motion during a head scan. The motion results are derived from the MR image data as it is being acquired.  MR images can be imported during the scan and analyzed to detect patient motion in real-time, providing the operator and patient with a tool for motion suppression.  The latest version, FIRMM 5 enhances the user interface, provides image quality and remaining scan-time metrics and integrates patient biofeedback.

More on TelAve News

• Lawsuit Alleges American Deli Food Caused Severe Illness, Acute Kidney Failure, And Eight-day Hospitalization
• FBI/DoW plot uncovered to hurt Trump/Vance through encouraged "widespread" cybersecurity breaches and racketeering theft of $80m in USDA payments
• Bettingbladet releases H1 2026 report on the Swedish online gambling market
• Garage door installation or repair in Minnesota? Which makes more sense for your family?
• Super Rooter Expands to 190 Plumbing, Sewer, and Drain Service Locations Across the United States

"This important milestone puts NOUS in a position to launch FIRMM 5 by the end of this year," said Ken Bruener, President and CEO of NOUS Imaging.  "FDA clearance validates the data we have collected with our research software over the past two years, and we are excited to offer a commercial version to our leading academic collaborators as well as hospitals and imaging centers throughout the US."

Damien Fair, PA-C, PhD, Director of the Masonic Institute of the Developing Brain, and Professor of Pediatrics and the Institute of Child Development at the University of Minnesota and Nico Dosenbach, MD, PhD, Associate Professor of Neurology and Radiology at Washington University School of Medicine founded NOUS Imaging and developed FIRMM to reduce the effect of motion on MRI scans. The software-only solution uses MR images directly and does not require a camera or other sensing hardware to be installed on the scanner.  In addition, FIRMM measures and displays movements of less than 1/10^th of a millimetter and enables the MRI scanner operator to control for motion that cannot be sensed by the patient.

More on TelAve News

• European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
• VICTURY Sports Announces Formation of Youth Sports League Built on the Official, Patented, and Award-Winning Keepy Uppy® Ball
• Congressman Chuck Edwards (NC-11) Presents ReadyCommunities Partnership 2026 National Service Award to Local Businessman / US Air Force Veteran
• Cress Creeks Farm Opens Fall Corn Maze and Baby Lamb Hayride Experience in Ellijay, Georgia
• Allstream Energy Partners Nominated in Multiple Categories for Fast Company's Best Workplaces for Innovators

About NOUS Imaging

NOUS Imaging is a transformational medical imaging software company developing unique solutions in the MR space.  Future applications are poised to revolutionize the way MR images are acquired and utilized in both adult and pediatric populations.  The NOUS mission is to deliver cost-effective imaging enhancements, establish next generation data analytics, and create a new patient centric experience in the MR suite. For additional information please visit NOUS Imaging's website at www.nousimaging.com